Updates matching "Indiana"

Allie Kast was recently promoted to government relations director for the American Cancer Society Cancer Action Network (ACS CAN). In this role, Kast will lead ACS CAN’s efforts in the state to advance legislation and public policies to reduce cancer.

INDIANAPOLIS, IN – “Yesterday, the Indiana House passed a budget that fails to prioritize reducing Indiana’s high tobacco burden. State representatives missed an opportunity to improve Hoosier health by reducing tobacco use, leaving out fact-based policies on the leading cause of preventable death in Indiana. “If Indiana is going

Indiana Must Do Better to Reduce the Burden of Cancer by Passing Fact-Based Legislation

As lawmakers dive into the 2023 legislative session, the American Cancer Society Cancer Action Network (ACS CAN) urges Speaker Huston, Rep. Thompson, and Sen. Bray and Mishler to prioritize significantly increasing taxes on all tobacco products and investing in fact-based tobacco prevention and cessation programs to ease the burden of cancer on Hoosiers.

State Lawmakers Can and Must Do Better When it Comes to Tobacco Control.

Advocates Were Among the First to Meet In-Person with Members Since the Pandemic’s Start; Will Ask For Increased Cancer Research Funding

Congressman Larry Bucshon, M.D. received the National Distinguished Advocacy Award this week, the most prestigious award presented by the American Cancer Society Cancer Action Network (ACS CAN), in recognition of his significant contributions to the fight against cancer.

Statement from Bryan Hannon, Chair of Tobacco Free Indiana INDIANAPOLIS, IN. – “Yesterday, the legislature did a big favor for Big Tobacco by passing legislation that will lower tax rates and maintain loopholes for some of the very products that the tobacco industry has used to addict Hoosier kids.

INDIANAPOLIS, IN. – Today, our elected officials worked to reduce the burden of cancer on Hoosier by passing House Bill 1238, which will eliminate cost sharing for all preventative colorectal cancer screenings, including follow-up colonoscopies after an abnormal stool-based test for most private insurance plans. “Colorectal cancer remains the second